PTBP3 was highly expressed in most tumours and the overexpression of PTBP3 generally predicts poor overall survival and disease-free survival in patients of with adrenocortical carcinoma, lung squamous cell carcinoma, and pancreatic adenocarcinoma [17]. Here, PTBP3 is linked to squamous cell lung carcinoma.